Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07448467 | Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema. | completed | N/A | 50 | Uskudar UniversityOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07127315 | Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy | completed | N/A | 100 | Helwan UniversityOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT07755553 | Effect of a Mushroom Extract-Containing Topical Cosmetic Formulation During Breast Radiotherapy | completed | N/A | 50 | Hifas da Terra S.L.INDUSTRY | 1 | Aug 10, 2026 | clinicaltrials |
| NCT02206984 | Endocrine Response in Women With Invasive Lobular Breast Cancer | completed | Phase 2 | 201 | Priscilla McAuliffeOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT01547741 | Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer | completed | Phase 3 | 4,242 | NSABP Foundation IncNETWORK | 2 | Aug 6, 2026 | clinicaltrials |
| NCT07745946 | The Effect of Virtual Reality Glasses and Breathing Exercise on Anxiety | completed | N/A | 107 | Ankara Medipol UniversityOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06375707 | First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer | completed | Phase 2 | 74 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT02654119 | Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery | completed | Phase 2 | 20 | University of NebraskaOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT05754658 | African Cancer Genome: GMD | completed | — | 854 | Fox Chase Cancer CenterOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT06068257 | Tumor-Derived FGF19 | completed | — | 119 | University of Central FloridaOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT07040514 | 24GUT540 : Meeting of Breast Cancer Patients and Pathologists | completed | N/A | 21 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT06075758 | A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer | completed | — | 175 | Novartis PharmaceuticalsINDUSTRY | 3 | Jul 29, 2026 | clinicaltrials |
| NCT07590505 | Ultrahypofractionated Versus Normofractionated Sequential Boost After Whole-breast Radiation Therapy in Patients Treated With Breast-conserving Surgery for Breast Cancer(ULTIMO) | completed | Phase 3 | 132 | Cancer Research AntwerpOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT06604858 | Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer(TELESCOPE) | completed | Phase 2 | 31 | MedSIROTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT02252887 | Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy | completed | Phase 2 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT02876302 | Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer | completed | Phase 2 | 23 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07040631 | Hyaluronic Acid for Prevention of Post-Intubation Sore Throat and Hoarseness | completed | N/A | 132 | Pusan National University Yangsan HospitalOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07334626 | Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal Therapy(PilatesBCS2026) | completed | N/A | 60 | Benha UniversityOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07724314 | Effects of a Web-Based Alopecia Education Program in Women With Breast Cancer | completed | N/A | 68 | Gulay AkmanOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT04553926 | 'OLAP' (OLAparib Regulatory Post-marketing Surveillance)(OLAP) | completed | — | 661 | AstraZenecaINDUSTRY | 1 | Jul 23, 2026 | clinicaltrials |
| NCT03677427 | Comparing 5 and 15 Fractions for Whole Breast Irradiation After Breast Conserving Surgery(YO-HAI5) | completed | N/A | 488 | University Hospital, GhentOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT04537286 | First-line Nab-paclitaxel Plus Cisplatin Plus Camrelizumab in mTNBC Patients | completed | Phase 2 | 90 | Fudan UniversityOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT01340495 | Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy | completed | N/A | 70 | Massachusetts General HospitalOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| NCT01564056 | Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment(ASTER 70s) | completed | Phase 3 | 1,989 | UNICANCEROTHER | 2 | Jul 20, 2026 | clinicaltrials |
| NCT04758780 | Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer(OPALESCENCE) | completed | Phase 2 | 12 | Institut Cancerologie de l'OuestOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| NCT07714382 | Survival Outcomes of Residual Disease in Triple-Negative Breast Cancer(ReS-TNBC) | completed | — | 100 | Sohag UniversityOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| NCT04542135 | Sulindac and Breast Density in Women at Risk of Developing Breast Cancer | completed | Phase 2 | 61 | Alison StopeckOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT05634395 | Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment(GrannyFit) | completed | N/A | 200 | Institut CurieOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT05727553 | Implementation of Online Adaptive Radiotherapy for Breast Cancer Patients on Ethos (BREAST-ART)(BREAST-ART) | completed | — | 50 | Amsterdam UMC, location VUmcOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT06025799 | Nurse-Delivered Adapted MBSR During Breast Cancer Radiotherapy | completed | N/A | 100 | Alexandria UniversityOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT07300202 | A Phase I, Single-arm, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers | completed | Phase 1 | 15 | Oriplantee Company LimitedOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT06465368 | A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause | completed | Phase 2 | 121 | PfizerINDUSTRY | 13 | Jul 15, 2026 | clinicaltrials |
| NCT07702409 | Tai-Chi Exercise Reduces Fatigue in Breast Cancer Patients Undergoing Chemotherapy | completed | N/A | 61 | Chairul HudaOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT05113927 | Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery.(RCT) | completed | N/A | 613 | Perimeter Medical ImagingINDUSTRY | 1 | Jul 13, 2026 | clinicaltrials |
| NCT02364557 | Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival | completed | Phase 2 / Phase 3 | 129 | NRG OncologyOTHER | 4 | Jul 10, 2026 | clinicaltrials |
| NCT03180294 | Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer | completed | Phase 2 | 230 | NRG OncologyOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT04717050 | Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity | completed | N/A | 64 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT05064098 | Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients | completed | — | 48 | University of Colorado, DenverOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT05377684 | Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment(ROSE) | completed | — | 450 | IpsenINDUSTRY | 1 | Jul 10, 2026 | clinicaltrials |
| NCT06003114 | A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs | completed | — | 472 | PfizerINDUSTRY | 1 | Jul 10, 2026 | clinicaltrials |
| NCT02009449 | A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors(IVY) | completed | Phase 1 | 353 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 9, 2026 | clinicaltrials |
| NCT02743910 | Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer | completed | — | 228 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 9, 2026 | clinicaltrials |
| NCT05631795 | Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment(ALPINIST) | completed | Phase 4 | 40 | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 9, 2026 | clinicaltrials |
| NCT07693985 | Multimodal Exercise and Education Program in Metastatic Breast CancerMostrar más líneas(MBC_MME) | completed | N/A | 37 | University of ValenciaOTHER | 1 | Jul 9, 2026 | clinicaltrials |
| NCT03671330 | Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer. | completed | Phase 2 | 327 | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 8, 2026 | clinicaltrials |
| NCT04688762 | The E-consult Application for Patients With Breast Cancer: Interest in Empathy and Empowerment of Patients.(e-CONSULT) | completed | — | 207 | Centre Francois BaclesseOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT05365230 | A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer | completed | Phase 4 | 261 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT05565534 | Diabetes Care for Breast Cancer Patients | completed | N/A | 74 | Weill Medical College of Cornell UniversityOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT06115902 | A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer | completed | Phase 1 | 153 | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 8, 2026 | clinicaltrials |
| NCT06386263 | HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada(HER-TEMPO) | completed | — | 22 | AstraZenecaINDUSTRY | 1 | Jul 8, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Aug 12, 2026source: clinicaltrials